Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Schedule of number of cash-settled RSUs granted

​

​

​

​

​

​

​

​

Three months ended

​

​

March 31, 2025

​

​

Awards Granted (000's)

​

Weighted
Average
GDFV

​

​

​

​

​

​

QVCGA cash-settled RSUs (1)

​

126,658

​

​

N/A

QVCGA stock-settled RSUs, mainly to our President and CEO (2)

​

16,219

​

$

0.28

(1) Grants mainly vest equally over three years.
(2) Grant to Mr. Rawlinson was made in connection with his employment agreement and vests equally over three years (see note 8).
Schedule of number and weighted average GDFV of QVC Group stock-settled RSUs granted to certain officers, employees and directors

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

Weighted

​

​

​

Series A

​

Average

​

Series B

​

Average

​

​

​

(000's)

​

GDFV

​

(000's)

​

GDFV

​

Outstanding at January 1, 2025

 

8,760

​

$

2.35

​

296

​

$

5.01

​

Granted

 

16,219

​

$

0.28

​

—

​

$

—

​

Vested

 

(5,476)

​

$

3.02

​

(296)

​

$

5.01

​

Forfeited/Cancelled

 

(927)

​

$

1.40

​

—

​

$

—

​

Outstanding at March 31, 2025

 

18,576

​

$

0.39

​

—

​

$

—

 

Schedule of cash-settled RSUs and PSUs granted to certain officers and employees

​

​

​

​

​

​

​

​

​

​

​

QVCGA

​

QVCGA

​

Total QVCGA

​

​

​

RSUs

​

PSUs

​

RSUs & PSUs

​

​

​

(000's)

​

(000's)

​

(000's)

​

Outstanding at January 1, 2025

 

19,407

​

35,862

​

55,269

​

Granted

 

126,658

​

—

​

126,658

​

Vested

 

(6,502)

​

(933)

​

(7,435)

​

Forfeited/Cancelled

 

(540)

​

(19,016)

​

(19,556)

​

Outstanding at March 31, 2025

 

139,023

​

15,913

​

154,936

​

Common stock Series A  
Schedule of Share-Based payment arrangement, Activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series A

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2025

 

19,231

​

$

7.09

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

 

(2,646)

​

$

13.67

​

​

​

​

​

​

​

Options outstanding at March 31, 2025

 

16,585

​

$

6.04

 

1.9

years

​

$

—

​

Options exercisable at March 31, 2025

 

16,585

​

$

6.04

 

1.9

years

​

$

—

​

Common stock Series B  
Schedule of Share-Based payment arrangement, Activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series B

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2025

 

407

​

$

12.95

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

​

(360)

​

$

13.49

​

​

​

​

​

​

​

Options outstanding at March 31, 2025

 

47

​

$

8.76

 

0.9

years

​

$

—

​

Options exercisable at March 31, 2025

 

47

​

$

8.76

 

0.9

years

​

$

—

​

​

​